In the news release, Across Global Alliance Selects Wemedoo's oomnia® as Central Clinical Trial Infrastructure, issued 27-Feb-2025 by Across Global Alliance over PR Newswire, we are advised by the company that the news should be provided by Across Global Alliance instead of Wemedoo. The Wemedoo logo is also removed for the same reason. An additional grammatical edit is also made in the first paragraph. The complete, corrected release follows:

Across Global Alliance Selects Wemedoo's oomnia® as Central Clinical Trial Infrastructure

Across Global Alliance has partnered with Wemedoo AG to implement oomnia as its centralized clinical trial infrastructure, enhancing efficiency, compliance, and collaboration across its alliance members operating in over 90 countries.

SINGAPORE, Feb. 27, 2025 /PRNewswire/ -- Across Global Alliance, a strategic alliance of clinical research organizations (CROs) and Specialist Service Providers has selected oomnia®, Wemedoo's advanced clinical trial data management system, as its centralized digital infrastructure. This strategic decision aims to streamline clinical trial management, enhance real-time collaboration among alliance members, and ensure regulatory compliance in over 90 countries.

After an extensive evaluation of available solutions, oomnia emerged as the only system capable of meeting the alliance's complex operational needs. By integrating essential clinical trial functions, including EDC, CTMS, RTSM, and eTMF into a single, unified platform, oomnia eliminates inefficiencies caused by fragmented systems and disjointed data workflows.

"Running global clinical trials requires a system that facilitates seamless collaboration, eliminates unnecessary delays, and ensures data consistency across all sites. With oomnia, we have found a platform that meets these demands while maintaining compliance and operational flexibility," said Steven Bukvic, Chairman of the Across Global Alliance.

With oomnia as its digital backbone, Across Global Alliance ensures that all its clients and members benefit from a system that optimizes clinical trial execution, provides real-time data quality reviews, and is easy to navigate.

"This partnership with Across Global Alliance is another step toward transforming how clinical trials are managed. By providing a truly integrated and adaptive system, we enable alliance members to focus on scientific progress rather than administrative complexity," said Nina Cihoric, CEO of Wemedoo AG.

Contact: Steven Bukvic
Email: bukvics@across.global

For more information visit Wemedoo & Across Global Alliance

About Across Global Alliance

Across Global Alliance is a Singapore-based strategic alliance of globally operating clinical research organizations (CROs) and Specialist Service Providers. Through the integration of regional expertise with a unified operational framework, the alliance provides comprehensive clinical research services across diverse therapeutic areas. With its unified infrastructure, Across Global Alliance enables seamless coordination, data integrity, and operational excellence in global clinical research.

About Wemedoo

Wemedoo AG, a Swiss-based company specializes in healthcare data-driven solutions. By combining advanced technologies with deep clinical expertise, Wemedoo empowers research teams, CROs, and sponsors to conduct clinical trials more efficiently, reduce costs, and accelerate medical innovation.

View original content:https://www.prnewswire.co.uk/news-releases/across-global-alliance-selects-wemedoos-oomnia-as-central-clinical-trial-infrastructure-302387819.html

Tags

More Like This

Simbec-Orion and Avance Clinical Consolidates Partnership with Memorandum of Understanding

ALPLA Chooses Omada to Enhance Identity Governance and Administration Services

Clario Enters into Definitive Agreement to Acquire WCG's eCOA Business

Omada Selected by Dura Vermeer to Modernize Identity Governance and Administration

ebm-papst Inc. Chooses Omada as IGA Provider

Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials

Swiss Red Cross Selects Omada Identity Cloud for SaaS IGA Provider

Avance Clinical CEO and Asia Director Sign MOUs with Key Clinical Trial Sites in Korea around 2024 KoNECT